Pilot Clinical Trial to Assess the Safety of NMS-01 in Patients With Mild to Moderate Alzheimer's Disease
NCT:NCT07869238 · RECRUITING
广告
NCT编号NCT07869238
状态RECRUITING
开始日期2026-01-05
完成时间2026-11-30
SponsorNeumous Inc. (INDUSTRY)
First posted
Last updated
简要摘要
A single-center, single-arm, prospective, open-label, pilot clinical trial to evaluate the safety and efficacy of the Focused ultrasound stimulator system (NMS-01) for transient Blood-Brain Barrier (BBB) opening in patients with mild to moderate Alzheimer's disease
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。